← Back
$DTIL All transactions

PRECISION BIOSCIENCES INC

M 10b5-1 Plan

$ Value

Shares

8,888

Price

Filed

Jan 22

Insider

Name

Amoroso Michael

Title

President and CEO

CIK

0001830874

Roles

Director Officer

Transaction Details

Transaction Date

2026-01-20

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

124,463

Footnotes

Represents the vesting of Restricted Stock Units ("RSUs") on January 20, 2026. | Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. | The sales were effected pursuant to a Rule 10b5-1 plan adopted on August 2, 2024. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.97 to $4.30. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote | On January 20, 2023 the Reporting Person was granted RSUs, which vested in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. | On April 18, 2024 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. | On August 22, 2024 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Filing Info

Accession No.

0001628280-26-003149

Form Type

4

Issuer CIK

0001357874

Amoroso Michael's History

Date Ticker Type Value
2026-02-18 DTIL $79K
2026-02-17 DTIL M $0
2026-02-17 DTIL M $0
2026-01-26 ABEO A $0
2026-01-22 DTIL $145K
2026-01-20 DTIL M
2026-01-20 DTIL M
2026-01-20 DTIL M
2026-01-20 DTIL M $0
2026-01-20 DTIL M $0

Other Insiders at DTIL (90d)

Insider Bought Sold Last
Kelly John Alexander
Chief Financial Officer
$31K 2026-02-18
SMITH J. JEFFERSON
Chief Research Officer
$19K 2026-02-18
Scimeca Dario
General Counsel and Secretary
$19K 2026-02-18
Amoroso Michael
President and CEO
$79K 2026-02-18